title: [Controversies in the secondary prevention of stroke].
abstract: Stroke is the third leading cause of death and the main cause of prolonged disability of adults in industrialised countries. After a first transient ischemic attack or a first minor stroke, the risk of recurrence is 16 folds higher than in control subjects. Therefore each patient suspect of a first ischemic cerebral event should be evaluated for the presence of a specific cause which could be treated. If such a cause is not found, platelet antiaggregant medications should be started.
authors.affiliation: Service de Neurologie, CHU Liège. G.Hans@ulg.ac.be
authors.forename: G
authors.initials: G
authors.lastname: Hans
authors.forename: B
authors.initials: B
authors.lastname: Sadzot
authors.forename: G
authors.initials: G
authors.lastname: Moonen
mesh_terms: D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D016893:Carotid Stenosis / Q000150:complications / Q000628:therapy; D006344:Heart Septal Defects, Atrial / Q000150:complications / Q000628:therapy; D006801:Humans; D012307:Risk Factors; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*